Stephen P. Ducray, PhD, is the Clinical Science Lead in Bayer's Early Clinical Development Oncology team and previously served as a management consultant within Bayer Business Consulting. With a PhD in Pathology from the University of Cambridge, they investigated cancer biology and epigenetics. They have received multiple awards for top performance during their tenure at Bayer and contributed significantly to various projects, including a Medical i-Teams initiative at the University of Cambridge. Stephen's academic background includes a degree in Biochemistry from Trinity College Dublin and various roles in enhancing the start-up ecosystem through the Innovation Forum.
This person is not in the org chart
This person is not in any teams
This person is not in any offices